The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists
LC-MS/MS conditions Experiments were carried out on ThermoFisher Scientific Vanquish high-performance liquid chromatography connected to ThermoFisher Scientific TSQ Quantis triple quadrupole mass spectrometer
Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S
The antioxidants have a variety of distinct mechanisms of action through which they exert their biochemical effects and improve diabetic nerve dysfunction
Ethics declarations Competing interests A.O
Individuals with compromised immune systemsincluding those undergoing chemotherapy, taking immunosuppressive medications, or living with HIV/AIDSface a small but significant risk of probiotic-related infections